• 1. Incorporation of electrically charged N-alkyl amino acids into ribosomally synthesized peptides via post-translational conversion
  Takashi Kawakami,Toru Sasaki,Patrick C. Reid,Hiroshi Murakami Chem. Sci. 2014 5 887
• 2. Organic acid shift reagents for the discrimination of carbohydrate isobars by ion mobility-mass spectrometry
  Kristin R. McKenna,Li Li,Ramanarayanan Krishnamurthy,Charles L. Liotta,Facundo M. Fernández Analyst 2020 145 8008
• 3. Biocatalytic asymmetric Michael addition reaction of l-arginine to fumarate for the green synthesis of N-(([(4S)-4-amino-4-carboxy-butyl]amino)iminomethyl)-l-aspartic acid lithium salt (l-argininosuccinic acid lithium salt)
  B. Schoenenberger,A. Wszolek,R. Meier,H. Brundiek,M. Obkircher,R. Wohlgemuth RSC Adv. 2017 7 48952
• 4. Journal of the Royal Institute of Chemistry. January 1962
  J. R. Inst. Chem. 1962 86 1

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

N-Methyl-L-aspartic acid (CAS No. 4226-18-0): A Comprehensive Overview

N-Methyl-L-aspartic acid, identified by the chemical compound code CAS No. 4226-18-0, is a significant amino acid derivative that has garnered considerable attention in the field of biochemical research and pharmaceutical development. This compound, a methylated form of L-aspartic acid, exhibits unique properties that make it a valuable tool in various scientific applications, particularly in the study of neurotransmitter systems and synthetic chemistry.

The molecular structure of N-Methyl-L-aspartic acid consists of an aspartic acid backbone with an additional methyl group attached to the nitrogen atom. This modification imparts distinct biochemical characteristics, influencing its interaction with biological targets and its potential therapeutic applications. The compound's ability to mimic the behavior of endogenous amino acids has made it a subject of intense study in neurobiology and pharmacology.

In recent years, N-Methyl-L-aspartic acid has been extensively researched for its role in modulating neurotransmitter activity. Specifically, it has been found to interact with NMDA (N-methyl-D-aspartate) receptors, which are crucial for synaptic plasticity and learning processes. Unlike L-aspartic acid, which is a non-competitive antagonist at these receptors, N-Methyl-L-aspartic acid acts as a partial agonist, providing insights into the complex mechanisms governing neuronal communication.

One of the most compelling aspects of N-Methyl-L-aspartic acid is its potential in the development of novel therapeutic agents. Researchers have explored its utility in treating neurological disorders characterized by excitotoxicity, such as epilepsy and stroke. The compound's ability to modulate NMDA receptor activity suggests that it could serve as a precursor for drugs designed to protect against excessive neuronal stimulation.

Furthermore, the synthesis and characterization of N-Methyl-L-aspartic acid have contributed significantly to advancements in synthetic chemistry. The development of efficient synthetic routes has not only facilitated its production on an industrial scale but also provided valuable insights into the stereochemistry and reactivity of amino acid derivatives. These findings have broader implications for the design and synthesis of other biologically active molecules.

The pharmacological profile of N-Methyl-L-aspartic acid has also been investigated in preclinical models. Studies have demonstrated its potential to enhance cognitive functions by promoting long-term potentiation (LTP) in hippocampal neurons. This effect is particularly relevant in the context of neurodegenerative diseases, where LTP deficits are commonly observed. The compound's ability to support synaptic plasticity may offer a novel approach to mitigating cognitive decline.

Recent research has further highlighted the role of N-Methyl-L-aspartic acid in modulating inflammatory responses within neural tissues. Excessive activation of NMDA receptors can lead to neuroinflammation, a phenomenon that exacerbates tissue damage during conditions like ischemia or traumatic brain injury. By acting as a partial agonist, N-Methyl-L-aspartic acid may help regulate these inflammatory pathways, thereby reducing neuronal damage.

The industrial applications of N-Methyl-L-aspartic acid extend beyond pharmaceuticals into agricultural and food science domains. Its derivatives have been explored as growth factors and metabolic enhancers in microbial cultures, contributing to more efficient bioproduction processes. Additionally, its role as a flavor enhancer in certain food products underscores its versatility across multiple industries.

The regulatory landscape surrounding the production and use of N-Methyl-L-aspartic acid is also worth noting. As a compound with significant biological activity, it is subject to stringent quality control measures to ensure safety and efficacy in various applications. Regulatory bodies have established guidelines for its synthesis, handling, and distribution, reflecting its importance in both research and commercial settings.

In conclusion, N-Methyl-L-aspartic acid (CAS No. 4226-18-0) represents a fascinating compound with diverse applications in biochemical research and pharmaceutical development. Its unique interactions with NMDA receptors make it a valuable tool for studying neurological processes and developing novel therapeutic strategies. The ongoing research into its pharmacological properties continues to uncover new possibilities for treating neurological disorders and enhancing cognitive functions.

• 6384-92-5(NMDA)
• 159753-00-1(L-Aspartic acid, N-(2-carboxyethyl)-)
• 303750-06-3((+/-)-2-(Methylamino)succinic acid, monohydrate)
• 17833-53-3(N-Methyl-DL-aspartic acid)
• 41035-84-1(L-Aspartic acid,N-(carboxymethyl)-)
• 415719-09-4(Aspartic acid,N-(1,2-dicarboxyethyl)-, ammonium salt (1:3))
• 125677-11-4(n-(2-hydroxyethyl) aspartic acid)
• 64339-35-1(D-Aspartic acid, N-methyl-, sodium salt)
• 131669-35-7(D-Aspartic acid,N-[(1S)-1,2-dicarboxyethyl]-, rel-)
• 7408-20-0(L-Aspartic acid, N-(1,2-dicarboxyethyl)-)